Tenofovir alafenamide fumarate

DRUG4 trials

Sponsors

Asian Pacific Liver Center at Coalition of Inclusive Medicine, Third Affiliated Hospital, Sun Yat-Sen University, Institute of Liver and Biliary Sciences, India

Conditions

Chronic Hepatitis bCirrhosis Due to Hepatitis BHepatitis BHepatitis B VirusNon-cirrhotic, Chronic Hepatitis B

Phase 4

TAF Switch Study in Hepatitis B Monoinfection

Asian Pacific Liver Center at Coalition of Inclusive MedicineHepatitis B

Start: 2016-12-22End: 2017-11-01Updated: 2017-06-29

Unknown Phase

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.

RecruitingNCT04231565

Third Affiliated Hospital, Sun Yat-Sen UniversityHepatitis B Virus

Start: 2020-06-04End: 2027-07-01Target: 200Updated: 2024-03-01

The Efficacy and Safety of TAF vs Other NAs in Patients With LVL

Third Affiliated Hospital, Sun Yat-Sen UniversityChronic Hepatitis b, Cirrhosis Due to Hepatitis B

Start: 2020-08-03End: 2024-04-30Target: 200Updated: 2020-10-29

TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

RecruitingNCT05195450

Institute of Liver and Biliary Sciences, IndiaNon-cirrhotic, Chronic Hepatitis B

Start: 2022-02-23End: 2027-12-31Target: 200Updated: 2022-02-28

Related Papers

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.

2026-03-011 citations

Prognostic value of decline in model for end-stage liver disease score and hepatic encephalopathy in hepatitis B-related acute-on-chronic liver failure patients treated with plasma exchange

Scandinavian Journal of Gastroenterology2022-04-174 citations

Long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure: a retrospective study.

2022-04-029 citations

Tenofovir alafenamide fumarate therapy in subjects with positive HBV-DNA and normal levels of alanine transaminase: a study protocol for a randomised controlled trial

BMJ Open2021-08-011 citations